Cargando…

The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives

Newborn screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone by immunoassay remains controversial despite screening been available for almost 40 years. Screening is confounded by poor immunoassay specificity, fetal adrenal physiology, stress, and illness which can result in a la...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Hora, Mark, Heather, Natasha, Webster, Dianne, Albert, Benjamin, Hofman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578435/ https://www.ncbi.nlm.nih.gov/pubmed/37850096 http://dx.doi.org/10.3389/fendo.2023.1226284

Ejemplares similares

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2022)

Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry
por: Chesover, Alexander D, et al.
Publicado: (2019)

Clinical applications of genetic analysis and liquid chromatography tandem-mass spectrometry in rare types of congenital adrenal hyperplasia
por: Li, Zhuoguang, et al.
Publicado: (2021)

SAT-277 Re-Evaluation of the 17-Hydroxyprogesterone (17-OHP) Screening Threshold for Diagnosing Nonclassic Congenital Adrenal Hyperplasia (NCCAH) in the Era of Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS)
por: Chesover, Alexander, et al.
Publicado: (2019)

Steroid profiling using liquid chromatography mass spectrometry during adrenal vein sampling in patients with primary bilateral macronodular adrenocortical hyperplasia
por: Zhang, Ru, et al.
Publicado: (2022)

Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories
por: Gelb, Michael H., et al.
Publicado: (2022)

Assisted Reproduction in Congenital Adrenal Hyperplasia
por: Chatziaggelou, Anastasios, et al.
Publicado: (2019)

Serum Steroid Profiling by Liquid Chromatography–Tandem Mass Spectrometry for the Rapid Confirmation and Early Treatment of Congenital Adrenal Hyperplasia: A Neonatal Case Report
por: Cicalini, Ilaria, et al.
Publicado: (2019)

Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia
por: Tsai, Wen-Hsuan, et al.
Publicado: (2020)

Morphologic and Molecular Characterization of Adrenals and Adrenal Rest Affected by Congenital Adrenal Hyperplasia
por: Kolli, Vipula, et al.
Publicado: (2021)

Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome
por: Marino, Roxana, et al.
Publicado: (2022)

Coexistence of Congenital Adrenal Hyperplasia and Autoimmune Addison's Disease
por: Aslaksen, Sigrid, et al.
Publicado: (2019)

Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden
por: Sahlander, Fredrik, et al.
Publicado: (2022)

Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
por: Held, Patrice K., et al.
Publicado: (2020)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia
por: Kim, Mimi S., et al.
Publicado: (2022)

Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia
por: Barbot, Mattia, et al.
Publicado: (2022)

Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
por: Adriaansen, Bas P. H., et al.
Publicado: (2022)

Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
por: Zhang, Jin, et al.
Publicado: (2022)

Analysis of the Screening Results for Congenital Adrenal Hyperplasia Involving 7.85 Million Newborns in China: A Systematic Review and Meta-Analysis
por: Li, Zhuoguang, et al.
Publicado: (2021)

Genotype Is Associated to the Degree of Virilization in Patients With Classic Congenital Adrenal Hyperplasia
por: Neocleous, Vassos, et al.
Publicado: (2018)

Editorial: Congenital Adrenal Hyperplasia, Unresolved Issues and Implications on Clinical Management
por: Livadas, Sarantis, et al.
Publicado: (2020)

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
por: Balsamo, Antonio, et al.
Publicado: (2020)

The High Prevalence of Testicular Adrenal Rest Tumors in Adult Men With Congenital Adrenal Hyperplasia Is Correlated With ACTH Levels
por: Mazzilli, Rossella, et al.
Publicado: (2019)

Testicular Adrenal Rest Tumors in a Patient With Congenital Adrenal Hyperplasia
por: Yu, Su-Yuan, et al.
Publicado: (2022)

Clinical diagnostic value of liquid chromatography-tandem mass spectrometry method for primary aldosteronism in patients with hypertension: A systematic review and meta-analysis
por: Hua, Kai-Fang, et al.
Publicado: (2022)

A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia
por: Fiet, Jean, et al.
Publicado: (2017)

Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022)

Liquid chromatography–tandem mass spectrometry for clinical diagnostics
por: Thomas, Stefani N., et al.
Publicado: (2022)

Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency
por: Improda, Nicola, et al.
Publicado: (2019)

Metabolic Perspectives for Non-classical Congenital Adrenal Hyperplasia With Relation to the Classical Form of the Disease
por: Macut, Djuro, et al.
Publicado: (2019)

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022)

The clinical characteristics and quality of life of 248 pediatric and adult patients with Congenital Adrenal Hyperplasia
por: Shafaay, Edi A., et al.
Publicado: (2023)

Development of Second-Tier Liquid Chromatography-Tandem Mass Spectrometry Analysis for Expanded Newborn Screening in Japan
por: Shigematsu, Yosuke, et al.
Publicado: (2021)

Adrenal hyperplasias in childhood: An update
por: Pitsava, Georgia, et al.
Publicado: (2022)

Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016)

Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States
por: Edelman, Sari, et al.
Publicado: (2020)

Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
por: Bialk, Eric R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_toi4hl39beefojf9lr004omiqd